Expand SNOA Menu
SNOA MENU

SNOA Stock Summary and Trading Ideas (Sonoma Pharmaceuticals | NASDAQ:SNOA)

Sonoma Pharmaceuticals (SNOA) Frequently Asked Questions

What does Sonoma Pharmaceuticals do?

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

What symbol and exchange does Sonoma Pharmaceuticals shares trade?

Sonoma Pharmaceuticals trades on the NASDAQ stock market under the symbol SNOA.

What is Sonoma Pharmaceuticals stock price doing today?

As of December 17, 2025, SNOA stock price climbed to $3.55 with 41,733 million shares trading.

What is Sonoma Pharmaceuticals's Beta?

SNOA has a beta of 1.82, meaning it tends to be more sensitive to market movements. SNOA has a correlation of 0.07 to the broad based SPY ETF.

How much is Sonoma Pharmaceuticals worth?

SNOA has a market cap of $6.04 million. This is considered a Sub-Micro Cap stock.

How much money does Sonoma Pharmaceuticals make?

Last quarter Sonoma Pharmaceuticals reported $6 million in Revenue and -$.32 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.01.

What is the highest and lowest price Sonoma Pharmaceuticals traded in the last 3 year period?

In the last 3 years, SNOA traded as high as $53.60 and as low as $1.75.

What are the top ETFs holding Sonoma Pharmaceuticals?

The top ETF exchange traded funds that SNOA belongs to (by Net Assets): VXF.

Is Sonoma Pharmaceuticals (SNOA) a good investment?

SNOA has outperformed the market in the last year with a price return of +34.0% while the SPY ETF gained +11.8%. However, in the short term, SNOA had mixed performance relative to the market. It has underperformed in the last 3 months, returning -15.5% vs +2.0% return in SPY. But in the last 2 weeks, SNOA shares have fared better than the market returning +12.0% compared to SPY -1.5%.

What are the support and resistance levels for Sonoma Pharmaceuticals (SNOA)?

SNOA support price is $3.14 and resistance is $3.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNOA shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes